Gilead Sciences Inc (NASDAQ:GILD)

111.71
Delayed Data
As of May 22
 +0.49 / +0.44%
Today’s Change
78.50
Today|||52-Week Range
116.83
+18.51%
Year-to-Date

Today’s Trading

Previous close111.22
Today’s open110.70
Day’s range110.70 - 112.66
Volume12,079,030
Average volume (3 months)10,767,695
Market cap$163.4B
Dividend yield1.54%
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+30.95%
Earnings growth (next 5 years)+11.10%
Revenue growth (last year)+121.81%
P/E ratio12.7
Price/Sales5.76
Price/Book10.81

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-0.26-0.16%
BIIBBiogen-2.47-0.62%
BAXBaxter International...-0.17-0.25%
GEVASynageva BioPharma C...+2.32+1.08%
Data as of 4:04pm ET, 05/22/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.66
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers